Background The effects of pharmacological blood pressure lowering at normal or high-normal
blood pressure ranges in people with or without pre-existing cardiovascular disease …

Background Blood pressure lowering is an established strategy for preventing microvascular
and macrovascular complications of diabetes, but its role in the prevention of diabetes itself …

Background The effects of pharmacological blood-pressure-lowering on cardiovascular
outcomes in individuals aged 70 years and older, particularly when blood pressure is not …

Background Updatable estimates of COVID-19 onset, progression, and trajectories underpin
pandemic mitigation efforts. To identify and characterise disease trajectories, we aimed to …

Background Some studies have suggested a link between antihypertensive medication and
cancer, but the evidence is so far inconclusive. Thus, we aimed to investigate this …

Background Controversy exists as to whether the threshold for blood pressure-lowering
treatment should differ between people with and without type 2 diabetes. We aimed to …

Purpose of Review To review the recent large-scale randomised evidence on pharmacologic
reduction in blood pressure for the primary and secondary prevention of cardiovascular …

Objective Evidence from randomised trials of pharmacological treatments on long-term blood
pressure (BP) reduction is limited. We investigated the antihypertensive drug effects on BP …

Background How measures of long‐term exposure to elevated blood pressure might add to
the performance of “current” blood pressure in predicting future cardiovascular disease is …

Diabetes is a heterogenous, multimorbid disorder with a large variation in manifestations,
trajectories, and outcomes. The aim of this study is to validate a novel machine learning …